Management of Solid Renal Tumour Associated with Von Hippel-Lindau Disease

Zhang Jin,Huang Yi-ran,Liu Dong-ming,Zhou Li-xin,Xue Wei,Chen Qi,Dong Bai-jun,Pan Jia-hua,Xuan Han-qing
DOI: https://doi.org/10.1097/00029330-200711020-00022
IF: 6.133
2007-01-01
Chinese Medical Journal
Abstract:Von Hippel-Lindau (VHL) disease is a rare autosomal dominant disorder caused by germ line mutations of the VHL tumour suppressor gene. It predisposes affected individuals to develop a variety of neoplasms, including haemangioblastomas of the central nervous system, retinal angiomas, renal cell carcinomas (RCCs), pheochromocytomas and cysts of the kidneys and epididymis. Germ line VHL mutations have been found in all VHL disease families.(1) RCC occurs in 25% to 45% of patients with VHL disease and is one of the leading causes of death.(2) As the RCCs in VHL disease tend to be multifocal and bilateral, the management of them becomes complex. Here, we share our experience about the management of solid renal tumours in 18 Chinese patients with VHL disease.
What problem does this paper attempt to address?